The IVD Base Complex: Total Bilirubin, Direct Bilirubin - Vietnam Registration 240003093/PCBB-HN
Access comprehensive regulatory information for The IVD Base Complex: Total Bilirubin, Direct Bilirubin in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại B medical device is registered under number 240003093/PCBB-HN and manufactured by Zybio Inc.. The authorized representative in Vietnam is CÔNG TY TNHH KHOA HỌC P N D.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
240003093/PCBB-HN
000.00.19.H26-241111-0005
Theo theo phụ lục
Theo phụ lục
Technical Details
Total Bilirubin (TBIL) Kit (Vanadate Oxidation Method) (Product Code: 01.09.00.21.EC.01): In vitro test used to determine the concentration of total bilirubin in human clinical samples (serum or plasma). Clinically, the test is primarily used as a marker to evaluate disorders of bilirubin metabolism. Total Bilirubin (TBIL) Kit (Vanadate Oxidation Method) (Product Code: 01.09.00.21.EC.03): In vitro test used to determine the concentration of total bilirubin in human clinical samples (serum or plasma). Clinically, the test is primarily used as a marker to evaluate disorders of bilirubin metabolism. Direct Bilirubin (DBIL) Kit (Vanadate Oxidation Method) (Product Code: 01.09.00.20.EC.01): In vitro test used to determine the concentration of direct bilirubin in human clinical samples (serum or plasma). Clinically, the test is primarily used as a marker to evaluate disorders of bilirubin metabolism. Direct Bilirubin (DBIL) Kit (Vanadate Oxidation Method) (Product Code: 01.09.00.20.EC.02): In vitro test used to determine the concentration of direct bilirubin in human clinical samples (serum or plasma). Clinically, the test is primarily used as a marker to evaluate disorders of bilirubin metabolism.
Dates and Status
Nov 13, 2024

